透過您的圖書館登入
IP:3.137.172.68
  • 期刊

以多切面電腦斷層評估生物可吸收模架置放效果-病例報告

The Evaluation of Multislice Computed Tomography in Bioresorbable Vascular Scaffold Clinical Outcome

摘要


2014年七月生物可吸收模架(Bioresorbable Vascular Scaffold, BVS)在台灣開始冠狀動脈介入治療之應用。不同於裸金屬支架(Bare Metal Stent, BMS)與藥物塗層支架(Drug Eluting Stent, DES)會永久留存於人體內,主成分為聚乳酸之生物可吸收模架在置放後二至三年會完全被代謝為二氧化碳與水,僅留下不透X光的白金標記供術後追蹤之用。多切面電腦斷層掃描(Mulyislice computed tomography, MSCT)已被臨床應用於評估冠狀動脈狹窄,而金屬支架會引起模糊假影;生物可吸收模架的乳酸成分不會導致假影的產生,邊緣的白金標記卻有可能引起假影。本病例報告顯示多切面電腦斷層掃描評估生物可吸收模架的術後置放效果是可行的。

並列摘要


Bioresorbable vascular scaffold (BVS) was applied to interventional cardiology in Taiwan in July, 2014. BVS included the pre-mounted polymer poly (L-lactide, PLLA) scaffold coated with the antipoliferative drug. The absence of bare metal stent or drug eluting stent permanent implatation in coronary arteries, BVS would be gradually disappearance in 2-3 years, only platinum markers remained. Multislice computed tomography (MSCT) was clinically applicable for noninvasive coronary assessment, but its diagnostic accuracy has been impeded by blooming artifact by metallic stent. BVS was composed of PLLA which induced no artifact, but the markers in the edge may cause artifacts. In this case report, MSCT used for evaluating the outcome of BVS implantation is feasible.

延伸閱讀